(Reuters) -Chevron Corp said on Friday that its annual production forecast was near the low-end of its previously estimated range.

By Doyinsola Oladipo and Bianca Flowers NEW YORK U.S. hotel executives say they are betting on brands that

Alzheimer’s treatment developer Biogen is spending more than $7 billion to buy Reata Pharmaceuticals and bolster its rare disease treatments

Olena Romanova fled Ukraine for Poland when Russia invaded in February last year, leaving behind a successful facial...

Tech giants could face billions of dollars in fines for failing to tackle disinformation under proposed Australian laws, which a watchdog on Monday said would bring...

Tunisia's president is hosting the leaders of Italy, the Netherlands and the European Union for talks aimed at smoothing the way for an international bailout

By Howard Schneider WASHINGTON The U.S. central bank needs to raise interest rates further to control inflation in

China on Wednesday reported it had entered deflation for the first time since 2021 -- the latest indicator pointing to a slowdown...

Walgreens Boots Alliance Inc. shares tumbled after the pharmacy giant slashed its adjusted earnings forecast for the fiscal

HANOI Apple supplier Luxshare Precision Industry Co has been awarded a license to invest an additional $330 million

PT Rajawali Corp., an Indonesian conglomerate owned by tycoon Peter Sondakh, is considering selling its controlling interest in

By Amina Niasse NEW YORK U.S. in-store retail sales swelled last week by the most since December courtesy